Exhaustive Covid-19 vaccine delivery plan will be unveiled once clinical trials are completed: Tamil Nadu Health Dept

▴ Exhaustive Covid-19 vaccine delivery plan will be unveiled once clinical trials are completed: Tamil Nadu Health Dept
The Tamil Nadu Health Department has said an exhaustive Covid-19 vaccine delivery plan will be unveiled once their clinical trials are completed.

The Tamil Nadu Health Department has said an exhaustive Covid-19 vaccine delivery plan will be unveiled once their clinical trials are completed.

Meanwhile, the state witnessed 1,688 new cases yesterday, and the active caseload has dipped further to 13,404.
 

In Chennai, clinical trials of two vaccines are currently underway, as approved by the Indian Council for Medical Research. The Covishield, developed by Oxford University and the pharma major AstraZeneca, and Bharat Biotech’s Covaxin are the two vaccine candidates that are undergoing field trials in Chennai.

 
The state health minister Dr. Vijayabhaskar told reporters in Chennai yesterday that once the trials are over and the Union Government gives the go-ahead, the delivery mechanism will be put in place to cover the population in the state.

He urged the public to continue to wear masks and follow social distancing.

Tags : #India #TamilNadu #StateGovernment #HealthDepartment #Covid19Vaccine #ClinicalTrials #Covishield #DrVijayabhaskar #AstraZeneca #BharatBiotech

Related Stories

18 Feb

COVID increases the risk of diabetes, a study finds

Since the pandemic began, we have been hearing that people with comorbidities are at higher risk of contracting COVID infection because of low immunity. A recent study published in JAMA Network Open reveals that COVID-19 infection is associated with an increased risk of diabetes.

View
01 Feb

Pfizer receives CHMP positive opinion for Novel COVID-19 oral treatment

Latest corporate news update : Pharma Jan 1/2022

View
31 Jan

Pfizer and BioNTech starts clinical trial for Omicron vaccine

Omicron vaccine trial starts

View
29 Nov

Study finds gradual increase in COVID infection risk after second vaccine dose

Results confirm that protection wanes with time and suggest a third (booster) dose might be warranted

View
07 Oct

Studies confirm waning immunity from Pfizer's Covid-19 vaccine

Latest pharma news

View
04 Oct

What increases the risk of getting COVID to people who are vaccinated

Two weeks after your second COVID19 vaccine dose, the immunity against the virus will be at their peak

View
21 Sep

Success story of Aurobindo Pharma

In the period between 1988-89, the company only manufactured penicillin. They have since then expanded into antibiotics, anti-allergic, antiretrovirals, cardiovascular, central nervous system and gastroenterological categories.

View
20 Sep

Moderna's vaccine is the most effective, but Pfizer and J&J also protect well, CDC

Latest pharma news update

View
28 Aug

Pfizer jab side effects in 12-15 year olds at high risk of COVID-19 complications, mild to moderate

Study numbers are small, but data representative of those most likely to benefit

View
23 Jul

Pfizer provides update on U.S. FDA review of Abrocitinib and XELJANZ filings

Pharma News update

View

-Advertisements-




Trending Now

The Digital Sleep Thief: How Night-time Screen Addiction is Robbing You of Bed-time RestApril 02, 2025
KKR Launches ‘Knight Bite’ – A Digital Series That Serves Up Food, Fun, and Cricket!April 02, 2025
Crompton rolls out its all new range of Aura, Avancer & Jedi Air Coolers for an effortless summer cooling experienceApril 02, 2025
CARE Hospitals, Hi-Tech City Strengthens Orthopaedics Department with Renowned SurgeonsApril 02, 2025
World Autism Awareness Day: Breaking the Chains of Stigma in IndiaApril 02, 2025
From Scroll to Squint: How Reels Are Reshaping Your VisionApril 02, 2025
Moscow Center for Diagnostics and Telemedicine Receives License for Radiology Residency ProgramApril 02, 2025
CARE Hospitals Launches AI-Powered Non-Invasive Therapy – An innovative modality introduced in Telangana & Andhra PradeshApril 02, 2025
High-Rise Heart Attacks: Are Skyscrapers Turning Survival into a Race Against Time?April 02, 2025
DCDC’s $150 Crore Expansion: Can Innovative Clinics End India's Kidney Crisis?April 02, 2025
Medanta Rolls Out ‘Colon Tunnel on Wheels’ to Drive Awareness on Colorectal Cancer Prevention & Early DetectionApril 01, 2025
Zigly launches 2 pet hospitals, opens 4 new stores; expects ARR to more than double in 1-2 yearsApril 01, 2025
University of Leeds Announces International Masters Regional Scholarships for 2025April 01, 2025
Avantor Recognized with Two Prestigious Awards at Asia-Pacific Biopharma Excellence Awards 2025April 01, 2025
Foundation Stone Laid for Madhav Netralaya Eye Hospital & Research CentreApril 01, 2025
Doomscrolling at Midnight: How Indians Are Sacrificing Sleep for ScreensMarch 31, 2025
Essential Medicines Price Surge: Are Patients Paying the Price?March 31, 2025
Prioritize your health during the holy days of RamzanMarch 31, 2025
Tired of Stomach Cramps? These Simple Foods Can Heal Your GutMarch 31, 2025
Regional growth booming for startups in 2024 - QBO Innovation studyMarch 31, 2025